Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma
Titel:
Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma
Auteur:
Clement, Paul M.J. Dirven, Linda Eoli, Marica Sepulveda-Sanchez, Juan M. Walenkamp, Annemiek M.E. Frenel, Jean S. Franceschi, Enrico Weller, Michael Chinot, Olivier De Vos, Filip Y.F.L. Whenham, Nicolas Sanghera, Paul Looman, Jim Kundu, Madan G. Peter de Geus, Jan Nuyens, Sarah Spruyt, Maarten Gorlia, Thierry Coens, Corneel Golfinopoulos, Vassilis Reijneveld, Jaap C. van den Bent, Martin J.